DATA UNION CAP(08375): The proposed AI MaaS solution and related PAS technology upgrade are currently in the pilot testing phase.
Sumeet Capital (08375) has issued an announcement regarding the Pilot Algorithm System (PAS), a proprietary technology infrastructure developed by the group, which includes a series of algorithms and source code, software-as-a-service (SaaS) solutions provided by the group, and a cooperation framework agreement with SmartCloud Kuangshi on the procurement and supply of cloud computing and internet traffic services.
DATA UNION CAP (08375) announced that it has launched the Pilot Algorithm System (PAS), a proprietary technology infrastructure developed by the group, which includes a series of algorithms and source code, software as a service (SaaS) solutions provided by the group, and a cooperative framework agreement with ACFUN XUNSHI on the procurement and supply of cloud computing and internet traffic services. Following the recent release of PAS and SaaS solutions for digital marketing and customer loyalty management, the group has completed the technical upgrade and functionality expansion of PAS, making it a comprehensive digital marketing and AI reasoning infrastructure, preparing for the expansion of the group's product services in the field of innovative technology to provide enterprise-level AI model as a service (MaaS) solutions. These solutions will enable customers to utilize the group's computational algorithms and machine learning models developed by PAS, as well as its reasoning capabilities, to develop their own AI agents and automation tools. The AI MaaS solutions provided by the group can support the development of AI agent tools with various functions, including but not limited to assisting in administrative tasks, automating paperwork tasks, resource management, and content generation, and can be applied across industries such as finance, content creation, marketing, education, and other fields.
The group plans to provide AI MaaS solutions to its customers on an annual subscription basis, supplemented by a framework based on usage fees. The group expects that the AI MaaS business will generate revenue through a combination of: (i) annual subscription and usage license fees paid by customers, covering the use of computational algorithms and machine learning models provided by PAS, as well as standard updates, regular customer service, and technical support; (ii) usage-based fees calculated based on the number of tokens used, tokens being the discrete data units processed by the AI model during the reasoning, computation, and output generation process, ensuring that costs are proportional to the customer's usage level; (iii) additional fees for additional services and features, such as customized AI models developed according to specific customer needs.
As of the date of this announcement, the AI MaaS solutions and related PAS technology upgrades that the group plans to provide are currently in the pilot testing phase and are expected to be preliminarily launched by the end of the fourth quarter of 2026.
The board of directors believes that the development and imminent launch of the AI MaaS solutions business mentioned above will complement the group's SaaS solutions business, further enhancing the group's strategic position as an emerging innovative technology service provider, consolidating the group's presence in the fields of AI and the digital economy, and constantly enhancing its competitive advantage and revenue sources in the context of the continued growth in demand for AI and innovative technology services.
Related Articles

CHERY AUTO (09973) will distribute a final dividend of 0.86 yuan per share on June 26th.

SDITC (01697) recommends appointing Zhao Zikun as an executive director of the company.

A-share evening hot topic | Major breakthrough! China's first original nuclear drug approved, is it a good opportunity to go long in the pharmaceutical sector?
CHERY AUTO (09973) will distribute a final dividend of 0.86 yuan per share on June 26th.

SDITC (01697) recommends appointing Zhao Zikun as an executive director of the company.

A-share evening hot topic | Major breakthrough! China's first original nuclear drug approved, is it a good opportunity to go long in the pharmaceutical sector?

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


